Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114604173 | 11460417 | 3 | F | 2011 | 20160804 | 20150904 | 20160811 | EXP | US-GLAXOSMITHKLINE-US2015126882 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114604173 | 11460417 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 500/50 MCG 1 PUFF(S), BID | 5ZP9336 | 21077 | 1 | DF | INHALATION POWDER | BID | |||||
| 114604173 | 11460417 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | 21077 | 1 | DF | INHALATION POWDER | QD | ||||||
| 114604173 | 11460417 | 3 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | 21077 | 2 | DF | INHALATION POWDER | BID | ||||||
| 114604173 | 11460417 | 4 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | 6ZP3772 | 21077 | 1 | DF | INHALATION POWDER | BID | |||||
| 114604173 | 11460417 | 5 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 1 PUFF(S), PRN | F69K | 0 | 1 | DF | |||||||
| 114604173 | 11460417 | 6 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | U | 0 | |||||||||||
| 114604173 | 11460417 | 7 | C | LUMIGAN | BIMATOPROST | 1 | U | 0 | |||||||||||
| 114604173 | 11460417 | 8 | C | METOPROLOL. | METOPROLOL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114604173 | 11460417 | 1 | Chronic obstructive pulmonary disease |
| 114604173 | 11460417 | 2 | Asthma |
| 114604173 | 11460417 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114604173 | 11460417 | OT |
| 114604173 | 11460417 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114604173 | 11460417 | Asthenia | |
| 114604173 | 11460417 | Bronchitis | |
| 114604173 | 11460417 | Cataract | |
| 114604173 | 11460417 | Cataract operation | |
| 114604173 | 11460417 | Chest pain | |
| 114604173 | 11460417 | Cough | |
| 114604173 | 11460417 | Dysphonia | |
| 114604173 | 11460417 | Ear discomfort | |
| 114604173 | 11460417 | Inappropriate schedule of drug administration | |
| 114604173 | 11460417 | Influenza | |
| 114604173 | 11460417 | Inhalation therapy | |
| 114604173 | 11460417 | Lower respiratory tract congestion | |
| 114604173 | 11460417 | Malaise | |
| 114604173 | 11460417 | Pneumonia | |
| 114604173 | 11460417 | Pulmonary mass | |
| 114604173 | 11460417 | Sinus congestion | |
| 114604173 | 11460417 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |